SEC Form 4 · accession 0001415889-18-000738
Niagen Bioscience, Inc. · NAGE
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
A later amendment supersedes this filing — read the amendment. The figures below are kept as originally reported (version chain, not an overwrite).
Reporting owner
Robert N Fried
Officer — PRESIDENT, COO · Director
Period of report
May 15, 2018
Accepted (ET)
May 15, 2018 · 5:34 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001386570
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | May 15, 2018 | A | 10,000 | $3.63 | A | 926,574 | D | |
| Common StockF1 | holding | — | — | — | 12,744 | I | See Footnote |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F16,744 shares held by Jeremy Fried and 6,000 shares held by Benjamin Fried, who are both sons of Robert Fried.